Cover Image
Market Research Report

Patient Recruitment and Retention Services Market, 2019-2030

Published by ROOTS ANALYSIS Product code 808190
Published Content info 240 Pages
Delivery time: 1-2 business days
Price
Back to Top
Patient Recruitment and Retention Services Market, 2019-2030
Published: February 28, 2019 Content info: 240 Pages
Description

Overview

Clinical trials represent an arduous step in the drug development process and are crucial to understanding the safety and efficacy profiles of novel therapeutic interventions. As these trials are prone to delays, and can even fail altogether, they impose an immense financial pressure on sponsors. Amongst several known challenges, patient recruitment is considered to be one of the rate limiting steps when it comes to getting drugs to the market. It is estimated that 80% of clinical trials do not meet their designated patient enrolment deadlines. In fact, around 37% of research sites fail to meet their subject accrual goals, while more than 10% don't even enroll a single patient. In addition, retaining patients is also a matter of concern, considering that the approximate dropout rate across clinical studies is around 30%. Delays in product launch, due to inability of the sponsors to recruit / retain patients, are highly common and are estimated to result in an average loss of USD 8 million per day in opportunity costs, for a blockbuster drug.

The abovementioned challenges have led several players in the pharmaceutical industry to outsource their patient recruitment-related needs to capable, specialty service providers. Employing contract service providers has been shown to expedite the patient recruitment process. Such service providers employ a variety of outreach methods, such as social media, mobile technologies, electronic health records (EHRs) and real-world evidence (RWE), and, over time, have attained a vital role in the successful conduct of clinical research. Although some big pharma players carry out patient recruitment in-house, the growing complexity of clinical trials and demand for niche patient populations for studies evaluating orphan drugs / personalized medicines is likely to prompt more developer companies to outsource various aspects of their clinical research-related operations in the foreseen future. In fact, the market has recently witnessed the establishment of several partnerships, which include agreements between study sponsors and patient recruitment firms (outsourcing deals) and partnerships between stakeholders aimed to combine their respective services portfolios related to patient recruitment and retention (service alliances). This niche services industry has also witnessed some consolidation as multiple smaller players have been acquired by more established entities, in an effort to expand geographical reach.

Scope of the Report

The ‘Patient Recruitment and Retention Services, 2019-2030’ report offers a comprehensive study of the current scenario and future potential of the players providing patient enrollment and retention services. The study features an in-depth analysis, highlighting the capabilities of the various stakeholders in this domain. In addition to other elements, the study includes:

  • A detailed assessment of the current market landscape of companies offering patient recruitment and retention services, including information on over 10 types of patient outreach methods employed, types of services offered ([A] patient recruitment (including pre-screening and Institutional Review Board (IRB) / Ethics Committee (EC) submission), [B] patient retention (considering various strategies, such as the use of study-branded gifts, study-branded reminders, providing education and support materials, reimbursement programs, transportation programs, patient engagement web site, patient reconnect programs, mobile applications to track patient engagement and others) and [C] other associated services (including site identification and selection,study feasibility / protocol development, project management, clinical trial monitoring and other services), year of establishment, geographical location, and size of company. The chapter also covers an analysis of the geographical reach and therapeutic expertise of service providers, along with details on the payment model, patient recruitment platforms / technologies used, and the various certifications / accreditations awarded by regulatory bodies.
  • An analysis of the most active regions (in terms of patient recruitment activity), based on the locations of headquarters of companies engaged in this domain, featuring schematic world map representations that highlight key hubs across the globe.
  • An insightful 2X2 representation of the results of a competitiveness analysis of various service providers (segregated into three peer groups based on their employee count (small-sized (1-50 employees), mid-sized (50-200 employees) and large (>200 employees)), highlighting capable players in this domain, based on their respective capabilities.
  • Comprehensive profiles of patient recruitment and retention service providers, featuring information on the location of their headquarters, year of establishment, patient recruitment services / platforms portfolio, recent developments and a comprehensive future outlook.
  • An analysis of the partnerships that have been established in the recent past, covering outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing and development agreements, and other forms of partnerships.
  • A review of emerging trends in the industry, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention.

One of the key objectives of the report was to estimate the existing market size and review the potential growth opportunities for patient recruitment service providers over the coming decade. Based on several parameters, we have provided an informed estimate of the likely evolution of this market in the short to mid-term and long term, for the period 2019-2030. In addition, we have segmented the future opportunity across [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world). In order to account for the uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios portraying the conservative, base and optimistic tracks of the industry's evolution.

The opinions and insights presented in this study were influenced by discussions conducted with multiple stakeholders in this domain. The report features detailed transcripts of interviews held with the following individuals (in alphabetical order of company names):

  • Simon Klaasen (Co-founder and Managing Director, Link2Trials)
  • Hagit Nof (Chief Operation Officer and Business Development, nRollmed)
  • Paul Ivsin (Managing Director, Seeker Health)

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

Example Insights

Chapter Outlines

Chapter 2 is an executive summary of the insights captured in our research. It offers a high-level view on the current state of the patient recruitment and retention services market and describes the upcoming opportunity in short to mid-term and long term.

Chapter 3 provides a general introduction to the patient recruitment and retention process in clinical trials. It includes a detailed discussion on the different phases of clinical trials, patient recruitment and its associated challenges, various strategies used to enhance patient accrual, affiliated ethical considerations and outsourcing activity in this domain. Further, it includes a detailed discussion on the various patient recruitment services offered by different contract service providers. Additionally, the chapter features a discussion on diverse patient retention strategies that are presently being employed to prevent enrolled participants from dropping out of clinical research studies.

Chapter 4 provides a comprehensive overview of the various types of patient outreach methods used by contract service providers in this domain, to identify and enroll patients in clinical trials. The chapter also highlights the various advantages and limitations of these outreach methods.

Chapter 5 provides a comprehensive view of the current market landscape of companies that offer patient recruitment and retention services. It presents detailed analyses on the basis of their year of establishment, geographical location, size of company, type of services offered, type of patient outreach methods, geographical reach, and the therapeutic expertise of service providers. In addition, it includes details on the payment model, patient recruitment platforms / technologies used, and the various certifications / accreditations awarded to companies, by regulatory bodies from across the world.

Chapter 6 features a competitiveness analysis of the companies providing patient recruitment and retention services based on various parameters, such as patient outreach methods, number of patient recruitment and retention services offered, therapeutic expertise, geographical reach and year of establishment. In the chapter, stakeholder entities have been plotted on a 2X2 matrix, having a company's Experience (based on its year of establishment)(abscissa) and Company Competitiveness (ordinate) as the two axes.

Chapter 7 features detailed profiles of key stakeholders in this industry; each profile provides information on their headquarters, year of establishment, patient recruitment services / platforms portfolio, recent developments and a comprehensive future outlook.

Chapter 8 features an elaborate discussion and analysis of the various partnerships / collaborations that have been inked amongst players in this market. It includes a brief description on the various types of partnership models (outsourcing agreements, service alliances, acquisitions, joint ventures, mergers, technology licensing agreements, development agreements, and others) adopted by industry stakeholders, highlighting the most common forms of deals / agreements that have been established in the period between 2013-2018.

Chapter 9 provides a detailed overview of the prevalent trends in the patient recruitment and retention services domain, including the use of social media, mobile technologies, EHRs and RWE, to overcome the challenges associated with patient recruitment and retention in clinical research.

Chapter 10 features a detailed discussion on the upcoming opportunities (such as rise in the number of clinical trials, development of personalized medicine / orphan drugs, growing opportunities in emerging markets, increasing preference for one-stop solutions and others) in the field of patient recruitment and retention that are likely to impact the evolution of the market over the coming years.

Chapter 11 features a comprehensive market forecast analysis, highlighting the future potential of patient recruitment services market till the year 2030. We have segmented the projected opportunity on the basis of [A] therapeutic area (oncology, infectious diseases, cardiovascular diseases, CNS disorders, respiratory disorders, metabolic disorders, and others), [B] steps in patient recruitment process (pre-screening and screening), [C] phases of development (phase I, phase II, phase III and phase IV), and [D] different global regions (North America, Europe, Asia-Pacific and rest of the world).

Chapter 12 summarizes the entire report. It presents a list of key takeaways from the report, and offers our independent opinion on the current market scenario.

Chapter 13 is a collection of interview transcripts of the discussions that were held with key stakeholders in this market. The chapter provides details of interviews held with Simon Klaasen (Co-founder and Managing Director, Link2Trials), Hagit Nof (Chief Operation Officer and Business Development, nRollmed) and Paul Ivsin (Managing Director, Seeker Health).

Chapter 14 is an appendix, which provides tabulated data and numbers for all the figures included in the report.

Chapter 15 is an appendix, which provides the list of companies and organizations mentioned in the report.

Table of Contents
Product Code: RA100128

Table of Contents

1. PREFACE

  • 1.1. Scope of the Report
  • 1.2. Research Methodology
  • 1.3. Chapter Outlines

2. EXECUTIVE SUMMARY

  • 3. PATIENT RECRUITMENT AND RETENTION IN CLINICAL TRIALS
  • 3.1. Chapter Overview
  • 3.2. Clinical Trials
    • 3.2.1. Clinical Trial Phases
  • 3.3. Patient Recruitment
    • 3.3.1. The Patient Recruitment Process
    • 3.3.2. Challenges Associated with Patient Recruitment
    • 3.3.3. Strategies to Improve Patient Recruitment
    • 3.3.4. Ethical Considerations
  • 3.4. Outsourcing of Patient Recruitment
    • 3.4.1. Patient Recruitment Services
  • 3.5. Patient Retention
    • 3.5.1. Patient Retention Services

4. PATIENT OUTREACH METHODS

  • 4.1. Chapter Overview
  • 4.2. Patient Outreach Methods
    • 4.2.1. Traditional Media
      • 4.2.1.1. Physician Referrals
      • 4.2.1.2. Television
      • 4.2.1.3. Radio
      • 4.2.1.4. Print Media (Newspaper, Flyers, Brochures and Posters)
      • 4.2.1.5. Direct Mail Campaigns
      • 4.2.1.6. Cold Call / Call Center
      • 4.2.1.7. Advantages and Limitations of Traditional Media
    • 4.2.2. Emerging / Novel Methods
      • 4.2.2.1. Social Media
        • 4.2.2.1.1. Social Media Platforms Used in Patient Recruitment
          • 4.2.2.1.1.1. Geo-Social Media
          • 4.2.2.1.1.2. Social Networking Websites
        • 4.2.2.1.2. Advantages and Limitations of Social Media
      • 4.2.2.2. Mobile / Software Applications
      • 4.2.2.3. Patient Networks
      • 4.2.2.4. Patient Advocacy Groups
      • 4.2.2.5. Electronic Medical Records (EMRs) / Electronic Health Records (EHRs) and Other Health Data
      • 4.2.2.6. Promotion of Trials in Indication Specific Events for Patients
    • 4.2.3. Best Practices / Recommendations for Patient Outreach

5. COMPETITIVE MARKET LANDSCAPE OF PATIENT RECRUITMENT AND RETENTION SERVICE PROVIDERS

  • 5.1. Chapter Overview
  • 5.2. Patient Recruitment and Retention Service Providers: Overall Market Landscape
    • 5.2.1. Analysis by Year of Establishment
    • 5.2.2. Analysis by Company Size
    • 5.2.3. Analysis by Geography
    • 5.2.4. Analysis by Patient Recruitment and Retention Services Offered
    • 5.2.5. Analysis by Patient Outreach Methods
    • 5.2.6. Analysis by Patient Recruitment Associated Services
    • 5.2.7. Analysis by Patient Retention Methods
    • 5.2.8. Analysis by Geographical Reach
    • 5.2.9. Analysis by Therapeutic Expertise
    • 5.2.10. Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status

6. COMPANY COMPETITIVENESS ANALYSIS

  • 6.1. Chapter Overview
  • 6.2. Methodology
  • 6.3. Assumptions and Key Parameters
  • 6.4. Patient Recruitment and Retention Service Providers: Company Competitiveness Analysis
    • 6.4.1. Small-Sized Companies
    • 6.4.2. Mid-Sized Companies
    • 6.4.3. Large Companies

7. COMPANY PROFILES

  • 7.1. Chapter Overview
  • 7.2. Patient Recruitment Service Providers in North America
    • 7.2.1. Acurian
      • 7.2.1.1. Company Overview
      • 7.2.1.2. Financial Information
      • 7.2.1.3. Patient Recruitment and Retention Services
      • 7.2.1.4. Recent Developments
      • 7.2.1.5. Future Outlook
    • 7.2.2. BBK Worldwide
      • 7.2.2.1. Company Overview
      • 7.2.2.2. Financial Information
      • 7.2.2.3. Patient Recruitment and Retention Services
      • 7.2.2.4. Recent Developments
      • 7.2.2.5. Future Outlook
    • 7.2.3. Bright Pharmaceuticals Services
      • 7.2.3.1. Company Overview
      • 7.2.3.2. Patient Recruitment and Retention Services
      • 7.2.3.3. Future Outlook
    • 7.2.4. ClinEdge
      • 7.2.4.1. Company Overview
      • 7.2.4.2. Patient Recruitment and Retention Services
      • 7.2.4.3. Recent Developments
      • 7.2.4.4. Future Outlook
    • 7.2.5. CSSi
      • 7.2.5.1. Company Overview
      • 7.2.5.2. Patient Recruitment and Retention Services
      • 7.2.5.3. Recent Developments
      • 7.2.5.4. Future Outlook
    • 7.2.6. CTM
      • 7.2.6.1. Company Overview
      • 7.2.6.2. Patient Recruitment and Retention Services
      • 7.2.6.2 Future Outlook
    • 7.2.7. Integrated Clinical Trial Services (ICTS)
      • 7.2.7.1. Company Overview
      • 7.2.7.2. Patient Recruitment and Retention Services
      • 7.2.7.3. Recent Developments
      • 7.2.7.4. Future Outlook
    • 7.2.8. MMG
      • 7.2.8.1. Company Overview
      • 7.2.8.2. Patient Recruitment and Retention Services
      • 7.2.8.3. Future Outlook
    • 7.2.9. Topstone Research
      • 7.2.9.1. Company Overview
      • 7.2.9.2. Patient Recruitment and Retention Services
      • 7.2.9.3. Future Outlook
    • 7.2.10. WCCT Global
      • 7.2.10.1. Company Overview
      • 7.2.10.2. Financial Information
      • 7.2.10.3. Patient Recruitment Services
      • 7.2.10.4. Recent Developments
      • 7.2.10.5. Future Outlook
  • 7.3. Patient Recruitment Service Providers in Europe
    • 7.3.1. Antidote
      • 7.3.1.1. Company Overview
      • 7.3.1.2. Financial Information
      • 7.3.1.3. Patient Recruitment and Retention Services
      • 7.3.1.4. Recent Developments
      • 7.3.1.5. Future Outlook
    • 7.3.2. FIDELIS RESEARCH
      • 7.3.2.1. Company Overview
      • 7.3.2.2. Financial Information
      • 7.3.2.3. Patient Recruitment and Retention Services
      • 7.3.2.4. Recent Developments
      • 7.3.2.5. Future Outlook
    • 7.3.3. Ignite Data
      • 7.3.3.1. Company Overview
      • 7.3.3.2. Financial Information
      • 7.3.3.3. Patient Recruitment and Retention Services
      • 7.3.3.4. Future Outlook
    • 7.3.4. Polaris BioPharma Consulting
      • 7.3.4.1. Company Overview
      • 7.3.4.2. Patient Recruitment and Retention Services
      • 7.3.4.3. Recent Developments
    • 7.3.5. Tudor Reilly Health
      • 7.3.5.1. Company Overview
      • 7.3.5.2. Financial Information
      • 7.3.5.3. Patient Recruitment and Retention Services
      • 7.3.5.4. Recent Developments
      • 7.3.5.5. Future Outlook
  • 7.4. Patient Recruitment Services Providers in Asia Pacific
    • 7.4.1. CROèe
      • 7.4.1.1. Company Overview
      • 7.4.1.2. Patient Recruitment and Retention Services
      • 7.4.1.3. Recent Developments
      • 7.4.1.4. Future Outlook
    • 7.4.2. Jsure Healthmedia
      • 7.4.2.1. Company Overview
      • 7.4.2.2. Patient Recruitment and Retention Services
      • 7.4.2.3. Future Outlook
    • 7.4.3. TrialWire
      • 7.4.3.1. Company Overview
      • 7.4.3.2. Patient Recruitment and Retention Services
      • 7.4.3.3. Recent Developments
    • 7.4.4. Pacific Groove
      • 7.4.4.1. Company Overview
      • 7.4.4.2. Patient Recruitment and Retention Services
      • 7.4.4.3. Recent Developments
      • 7.4.4.4. Future Outlook

8. PARTNERSHIPS AND COLLABORATIONS

  • 8.1. Chapter Overview
  • 8.2. Partnership Models
  • 8.3. Patient Recruitment and Retention Services: List of Partnerships and Collaborations
    • 8.3.1. Analysis by Year of Partnerships
    • 8.3.2. Analysis by Type of Partnership
    • 8.3.3. Analysis by Purpose of Agreement
    • 8.3.4. Analysis by Therapeutic Area
    • 8.3.5. Most Active Players: Analysis by Number of Partnerships
    • 8.3.6. Geographical Analysis
      • 8.3.6.1. Intercontinental and Intracontinental Agreements

9. RECENT TRENDS IN PATIENT RECRUITMENT AND RETENTION

  • 9.1. Chapter Overview
    • 9.1.1. Social Media-based Campaigning to Accelerate Patient Recruitment in Clinical Trials
    • 9.1.2. Adoption of Mobile Technologies for Patient Recruitment and Retention
    • 9.1.3. Use of EHR Data to Improve Patient Recruitment Rates
    • 9.1.4. Other Real World Data Sources to Help Overcome Patient Recruitment-Related Challenges
    • 9.1.5. Growing Focus on Conducting Clinical Research in Emerging Markets

10. FUTURE GROWTH OPPORTUNITIES

  • 10.1. Chapter Overview
    • 10.1.1. Anticipated Increase in the Number of Global Clinical Trials
    • 10.1.2. Growing Demand for Orphan Drugs and Personalized Medicine
    • 10.1.3. Increased Offshoring of Clinical Development Operations to Emerging Regions
    • 10.1.4. Availability of Service Providers Offering One-Stop-Solutions
    • 10.1.5. Stringent Regulations and Complex Study Protocols Expected to Promote Outsourcing

11. MARKET SIZING AND OPPORTUNITY ANALYSIS

  • 11.1. Chapter Overview
  • 11.2. Forecast Methodology and Key Assumptions
  • 11.3. Overall Patient Recruitment Services Market, 2019-2030
  • 11.4. Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019-2030
  • 11.5. Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030
  • 11.6. Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030
  • 11.7. Patient Recruitment Services Market: Distribution by Geography, 2019-2030
    • 11.7.1. Patient Recruitment Services Market: Market Attractiveness Analysis by Country, 2019-2030
    • 11.7.2. Patient Recruitment Services Market in North America, 2019-2030
      • 11.7.2.1. Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030
      • 11.7.2.2. Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030
      • 11.7.2.3. Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030
      • 11.7.2.4. Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030
    • 11.7.3. Patient Recruitment Services Market in EU5, 2019-2030
      • 11.7.3.1. Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030
      • 11.7.3.2. Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030
      • 11.7.3.3. Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030
      • 11.7.3.4. Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030
      • 11.7.3.5. Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030
      • 11.7.3.6. Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030
      • 11.7.3.7. Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030
      • 11.7.3.8. Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030
      • 11.7.3.9. Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030
      • 11.7.3.10. Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030
    • 11.7.4. Patient Recruitment Services Market in Asia Pacific, 2019-2030
      • 11.7.4.1. Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030
      • 11.7.4.2. Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030
      • 11.7.4.3. Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030
      • 11.7.4.4. Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030
      • 11.7.4.5. Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030
      • 11.7.4.6. Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030
      • 11.7.4.7. Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030
      • 11.7.4.8. Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030
      • 11.7.4.9. Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030
      • 11.7.4.10. Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030
    • 11.7.5. Patient Recruitment Services Market in Rest of the World, 2019-2030
      • 11.7.5.1. Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030
      • 11.7.5.2. Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030

12. CONCLUSION

  • 12.1. Evolving Requirements Related to Patient Enrolment have Imposed a Significant Burden on Drug Developers, Causing Many to Outsource their Recruitment and Retention-related Processes
  • 12.2. Several CROs Offer Patient Recruitment and Retention Services across the Globe; North America and Europe have Emerged as Key Hubs
  • 12.3. Currently, a Variety of Outreach Methods are being used to Enroll Patient from Across Different Geographies and Therapeutic Areas
  • 12.4. Innovation, Use of Real World Evidence and the Establishment of Strategic Alliances between Stakeholders are Anticipated to Act as Key Market Enablers
  • 12.5. Driven by the Increasing Demand for Niche and Highly Specific Patient Populations in Clinical Trials, the Patient Recruitment Services Market is Anticipated to Witness Significant Growth in the Coming Decade

13. INTERVIEW TRANSCRIPTS

  • 13.1. Chapter Overview
  • 13.2. Link2Trials
    • 13.2.1. Interview Transcript: Simon Klaasen, Co-founder and Managing Director
  • 13.3. nRollmed
    • 13.3.1. Interview Transcript: Hagit Nof, Chief Operation Officer and Business Development Officer
  • 13.4. Seeker Health
    • 13.4.1. Interview Transcript: Paul Ivsin, Managing Director

14. APPENDIX 1: TABULATED DATA

15. APPENDIX 2: LIST OF COMPANIES AND ORGANIZATIONS

List of Figures

  • Figure 3.1: Factors Contributing to Clinical Trial Costs
  • Figure 3.2: The Patient Recruitment Process
  • Figure 3.3: Factors Influencing Participation in Clinical Trials
  • Figure 3.4: Reasons for Patient Dropouts from Clinical Studies
  • Figure 4.1: Patient Recruitment: Advantages and Limitations of Traditional Media
  • Figure 4.2: Patient Recruitment: Advantages and Limitations of Social Media
  • Figure 5.1: Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment
  • Figure 5.2: Patient Recruitment and Retention Service Providers: Distribution by Company Size
  • Figure 5.3: Patient Recruitment and Retention Service Providers: Distribution by Geography
  • Figure 5.4: Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size
  • Figure 5.5: Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
  • Figure 5.6: Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods
  • Figure 5.7: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
  • Figure 5.8: Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services
  • Figure 5.9: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered
  • Figure 5.10: Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods
  • Figure 5.11: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods
  • Figure 5.12: Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach
  • Figure 5.13: Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise
  • Figure 6.1: Company Competitiveness Analysis: Small-Sized Players
  • Figure 6.2: Company Competitiveness Analysis: Mid-Sized Players
  • Figure 6.3: Company Competitiveness Analysis: Large Players
  • Figure 7.1: Acurian: Innovative Tools / Approaches for Patient Recruitment
  • Figure 7.2: Acurian: Patient Recruitment Solutions and Strategies
  • Figure 7.3: BBK Worldwide: Service Portfolio
  • Figure 7.4: Bright Pharmaceutical Services: Service Portfolio
  • Figure 7.5: ClinEdge: Service Portfolio
  • Figure 7.6: CSSi: Patient Recruitment and Retention Capabilities
  • Figure 7.7: CSSi: Patient Recruitment Strategies
  • Figure 7.8: CTM: Patient Recruitment Process
  • Figure 7.9: CTM: Outreach Methods Used to Recruit Patients
  • Figure 7.10: CTM: Technologies Used to Recruit Patients
  • Figure 7.11: Topstone Research: Service Portfolio
  • Figure 7.12: Antidote: Services Portfolio
  • Figure 7.13: Antidote Base: Patient Recruitment Process
  • Figure 7.14: Fidelis Research: Service Portfolio
  • Figure 7.15: Ignite Data: Patient Recruitment and Call-Screening Process
  • Figure 7.16: Ignite Data: Patient Recruitment and Retention Strategies
  • Figure 7.17: Ignite Data: Real-World Data Delivery Process
  • Figure 7.18: Polaris Biopharma Consulting: Core Capabilities
  • Figure 7.19: Polaris Biopharma Consulting: Service Portfolio
  • Figure 7.20: Tudor Reilly Health: Service Portfolio
  • Figure 7.21: Tudor Reilly Health: Local Support Divisions
  • Figure 7.22: CROèe: Service Portfolio
  • Figure 7.23: TrialWire: Patient Recruitment Process
  • Figure 7.24: TrialWire: The RapidRecruit Platform
  • Figure 7.25: Pacific Groove: Business Divisions
  • Figure 7.26: Pacific Groove: Patient Enrollment Process
  • Figure 8.1: Partnerships and Collaborations: Distribution by Year, 2013-2018
  • Figure 8.2: Partnerships and Collaborations: Distribution by Type of Partnership
  • Figure 8.3: Partnerships and Collaborations: Distribution by Purpose of Agreement
  • Figure 8.4: Partnerships and Collaborations: Analysis by Therapeutic Area
  • Figure 8.5: Partnerships and Collaborations: Most Active Players
  • Figure 8.6: Partnerships and Collaborations: Intercontinental and Intracontinental Distribution
  • Figure 9.1: Recent Trends in Patient Recruitment and Retention
  • Figure 10.1: Patient Recruitment Services Market: Future Growth Opportunities
  • Figure 10.2: Number of Global Clinical Trials Registered by Year, 2000-2018
  • Figure 10.3: Evolution of Clinical Trial Regulations in the US
  • Figure 11.1: Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
  • Figure 11.2: Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)
  • Figure 11.3: Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
  • Figure 11.4: Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.5: Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
  • Figure 11.6: Patient Recruitment Services Market: Market Attractiveness Analysis by Country
  • Figure 11.7: Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
  • Figure 11.8: Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.9: Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.10: Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.11: Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.12: Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
  • Figure 11.13: Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.14: Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.15: Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.16: Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.17: Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.18: Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.19: Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.20: Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.21: Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.22: Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.23: Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
  • Figure 11.24: Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.25: Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.26: Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.27: Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.28: Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.29: Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.30: Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.31: Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.32: Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.33: Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 11.34: Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
  • Figure 11.35: Patient Recruitment Services Market in Rest of the World: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Figure 11.36: Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Figure 12.1: Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

List of Tables

  • Table 3.1: Salient Features of Clinical Trial Phases
  • Table 4.1: Traditional and Emerging Patient Outreach Methods
  • Table 5.1: List of Patient Recruitment and Retention Service Providers
  • Table 5.2: Patient Recruitment and Retention Service Providers: Information on Patient Outreach Methods
  • Table 5.3: Patient Recruitment and Retention Service Providers: Information on Type of Patient Recruitment Services
  • Table 5.4: Patient Recruitment and Retention Service Providers: Information on Patient Retention Methods
  • Table 5.5: Patient Recruitment and Retention Service Providers: Information on Geographical Reach
  • Table 5.6: Patient Recruitment and Retention Service Providers: Information on Therapeutic Expertise
  • Table 5.7: Patient Recruitment and Retention Service Providers: Information on Payment Model, Recruitment Technology / Platform, and Regulatory Approval / Certification / Compliance Status
  • Table 7.1: Acurian: Funding
  • Table 7.2: Acurian: Future Outlook
  • Table 7.3: BBK Worldwide: Future Outlook
  • Table 7.4: ClinEdge: Future Outlook
  • Table 7.5: CSSi: Future Outlook
  • Table 7.6: WCCT Global: Future Outlook
  • Table 7.7: Antidote: Funding
  • Table 7.8: Antidote: Future Outlook
  • Table 7.9: Ignite Data: Future Outlook
  • Table 7.10: Tudor Reilly Health: Future Outlook
  • Table 7.11: CROèe: Future Outlook
  • Table 7.12: Pacific Groove: Future Outlook
  • Table 8.1: Patient Recruitment and Retention Services: Partnerships and Collaborations, 2013-2018
  • Table 14.1: Patient Recruitment and Retention Service Providers: Distribution by Year of Establishment
  • Table 14.2: Patient Recruitment and Retention Service Providers: Distribution by Company Size
  • Table 14.3: Patient Recruitment and Retention Service Providers: Distribution by Geography
  • Table 14.4: Patient Recruitment and Retention Service Providers: Distribution by Geography and Company Size
  • Table 14.5: Patient Recruitment and Retention Service Providers: Distribution by Type of Services Offered
  • Table 14.6: Patient Recruitment and Retention Service Providers: Distribution by Type of Patient Outreach Methods
  • Table 14.7: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Outreach Methods Offered
  • Table 14.8: Patient Recruitment and Retention Service Providers: Distribution by Patient Recruitment Associated Services
  • Table 14.9: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Recruitment Associated Services Offered
  • Table 14.10: Patient Recruitment and Retention Service Providers: Distribution by Patient Retention Methods
  • Table 14.11: Patient Recruitment and Retention Service Providers: Distribution by Number of Patient Retention Methods
  • Table 14.12: Patient Recruitment and Retention Service Providers: Distribution by Geographical Reach
  • Table 14.13: Patient Recruitment and Retention Service Providers: Distribution by Therapeutic Expertise
  • Table 14.14: Company Competitiveness Analysis: Small-Sized Players
  • Table 14.15: Company Competitiveness Analysis: Mid-Sized Players
  • Table 14.16: Company Competitiveness Analysis: Large Players
  • Table 14.17: Overall Patient Recruitment Services Market, 2019-2030 (USD Billion)
  • Table 14.18: Patient Recruitment Services Market: Distribution by Therapeutic Area, 2019 and 2030 (%)
  • Table 14.19: Patient Recruitment Services Market: Distribution by Steps in Patient Recruitment Process, 2019-2030 (USD Billion)
  • Table 14.20: Patient Recruitment Services Market: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.21: Patient Recruitment Services Market: Distribution by Geography, 2019-2030 (USD Billion)
  • Table 14.22: Patient Recruitment Services Market: Market Attractiveness Analysis by Country
  • Table 14.23: Patient Recruitment Services Market in North America, 2019-2030 (USD Billion)
  • Table 14.24: Patient Recruitment Services Market in the US: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.25: Patient Recruitment Services Market in the US: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.26: Patient Recruitment Services Market in Canada: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.27: Patient Recruitment Services Market in Canada: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.28: Patient Recruitment Services Market in EU5, 2019-2030 (USD Billion)
  • Table 14.29: Patient Recruitment Services Market in Germany: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.30: Patient Recruitment Services Market in Germany: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.31: Patient Recruitment Services Market in France: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.32: Patient Recruitment Services Market in France: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.33: Patient Recruitment Services Market in the UK: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.34: Patient Recruitment Services Market in the UK: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.35: Patient Recruitment Services Market in Italy: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.36: Patient Recruitment Services Market in Italy: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.37: Patient Recruitment Services Market in Spain: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.38: Patient Recruitment Services Market in Spain: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.39: Patient Recruitment Services Market in Asia Pacific, 2019-2030 (USD Billion)
  • Table 14.40: Patient Recruitment Services Market in Japan: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.41: Patient Recruitment Services Market in Japan: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.42: Patient Recruitment Services Market in South Korea: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.43: Patient Recruitment Services Market in South Korea: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.44: Patient Recruitment Services Market in Australia: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.45: Patient Recruitment Services Market in Australia: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.46: Patient Recruitment Services Market in China: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.47: Patient Recruitment Services Market in China: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.48: Patient Recruitment Services Market in India: Distribution by Phase of Development, 2019-2030 (USD Billion)
  • Table 14.49: Patient Recruitment Services Market in India: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.50: Patient Recruitment Services Market in Rest of the World, 2019-2030 (USD Billion)
  • Table 14.51: Phases of Development, 2019-2030 (USD Billion)
  • Table 14.52: Patient Recruitment Services Market in Rest of the World: Distribution by Therapeutic Area, 2019-2030 (USD Billion)
  • Table 14.53: Patient Recruitment and Retention Market: 2019 and 2030 (USD Billion)

Listed Companies

The following companies / institutes / government bodies and organizations have been mentioned in this report.

  • 1. Abnex
  • 2. Access Clinical Research
  • 3. Accurate Clinical Research
  • 4. Acurian
  • 5. Advanced Clinical
  • 6. AD VERBUM
  • 7. Affordable Clinical Trials Outsourcing
  • 8. Akcelis
  • 9. Alleco Trials
  • 10. Alliance for Clinical Research Excellence and Safety
  • 11. Allscripts
  • 12. American Liver Foundation
  • 13. American Society of Clinical Oncology
  • 14. Amgen
  • 15. Antidote
  • 16. ApotheCom
  • 17. Apparelyzed
  • 18. Apptomics
  • 19. AQLANE Medical
  • 20. Arden and Schmidt
  • 21. AstraZeneca
  • 22. ATLAS Medical Services
  • 23. AutoCruitment
  • 24. AXELLE Group
  • 25. Axiom Marketing
  • 26. BBK Worldwide
  • 27. BDD
  • 28. BIAPharm
  • 29. Bioclinica
  • 30. Bio-Optronics
  • 31. BioScript
  • 32. Bladder & Bowel Community
  • 33. Blueprint Clinical
  • 34. BlueTheory Clinical Trials
  • 35. BMC Group
  • 36. Box
  • 37. Bridge Clinical Research
  • 38. Bright Pharmaceutical Services
  • 39. Buzzreach
  • 40. CaringKind
  • 41. C&C Clinical Laboratory Consulting
  • 42. Canadian Institute for Medical Advancement
  • 43. Capsule Communications
  • 44. CarthagoPharma
  • 45. Center Point Clinical Services
  • 46. Centricity Health
  • 47. Chandler Chicco Agency
  • 48. Chase Medical Research
  • 49. Cinven
  • 50. Circuit Clinical
  • 51. Clariness
  • 52. Clear Clinica
  • 53. Clinart MENA
  • 54. ClinEdge
  • 55. Clinical Ambassador
  • 56. Clinical List America
  • 57. Clinical Trial
  • 58. Clinical Trial Connect
  • 59. Clinical Trials Group
  • 60. Clinical Trial Marketing Communications
  • 61. Clinical Trial Networking
  • 62. Clinical Trials Center
  • 63. ClinicalConnection
  • 64. Clinically Media
  • 65. ClinIntel
  • 66. Clinerion
  • 67. CliniSpan Health
  • 68. Clinspire Research
  • 69. Clintec
  • 70. Clintract
  • 71. Clinverse
  • 72. CMX Research
  • 73. Compass Research
  • 74. Continuum Clinical
  • 75. CPS Research
  • 76. CROee
  • 77. CSSi
  • 78. CTM
  • 79. Cyclone
  • 80. Cytespace
  • 81. DAC Patient Recruitment Services
  • 82. DAVA Oncology
  • 83. DrFirst
  • 84. Eastern Medical
  • 85. Effectus CTR
  • 86. EGeen
  • 87. Elligo Health Research
  • 88. EmergingMed
  • 89. eNre
  • 90. ePatientFinder
  • 91. eStudySite
  • 92. Euclid SR Partners
  • 93. European Organization for Research and Treatment of Cancer
  • 94. EVERSANA
  • 95. FDAMap
  • 96. Fidelis Research
  • 97. Flatiron Health
  • 98. Foundation for the National Institutes of Health
  • 99. Foundation Medicine
  • 100. Friends of Cancer Research
  • 101. Gaea Clinical
  • 102. Galen Patient Recruitment
  • 103. GCP Clinical Studies
  • 104. Genentech
  • 105. Gitzo Pharmaceuticals
  • 106. Global Clinical Trials
  • 107. Global Perspectives
  • 108. GuideStar Research
  • 109. Heron Therapeutics
  • 110. Ignite Data
  • 111. IMS Health
  • 112. Incontinence UK
  • 113. Innovative Trials
  • 114. INSPIRE
  • 115. Institute of Clinical Research India
  • 116. Integrated Clinical Trial Services
  • 117. IQVIA
  • 118. IRM
  • 119. JLL Partners
  • 120. JP Morgan Partners
  • 121. J Trotter Research & Consulting
  • 122. KCR
  • 123. Klick Health
  • 124. Langland
  • 125. LeadSlinger
  • 126. Link2Trials
  • 127. Linical Accelovance
  • 128. Live Doctors
  • 129. LongTaal
  • 130. Lyft
  • 131. Lymphoma Action
  • 132. Melanoma Research Alliance
  • 133. Medical Research South
  • 134. MediciGroup
  • 135. Merck Capital Ventures
  • 136. Miami Research Associates
  • 137. MMG
  • 138. Mondosano
  • 139. Mundipharma Research
  • 140. National Cancer Institute
  • 141. Northumbria Healthcare NHS Foundation Trust
  • 142. nRollmed
  • 143. O4 Research
  • 144. One Research
  • 145. orphan reach
  • 146. Orphanos
  • 147. Osaka International Cancer Institute
  • 148. Pacific Grove
  • 149. Parallel 6
  • 150. PAREXEL
  • 151. Patient Enrollment Advisors
  • 152. Patient RM
  • 153. PatientEvolution
  • 154. Patients Direct
  • 155. PatientWise
  • 156. Patiro
  • 157. Pepgra
  • 158. Pfizer
  • 159. PharmaCentra
  • 160. Pharmaceutical Product Development
  • 161. Pharm-Olam
  • 162. phaware global association
  • 163. Physicians Plasma Alliance
  • 164. Polaris Biopharma Consulting
  • 165. PPH plus
  • 166. Practice Fusion
  • 167. Praxis Communications
  • 168. PRC Clinical
  • 169. Profil
  • 170. ProQuest Investments
  • 171. Publicis Healthcare Communications Group
  • 172. PWNHealth
  • 173. QPS
  • 174. Radiant Research
  • 175. RealTime Software Solutions
  • 176. RemediumOne
  • 177. Remedy Health Media
  • 178. Rep Network
  • 179. RESolutions
  • 180. S4 Research
  • 181. Seeker Health
  • 182. Sinque Labs
  • 183. SitePartner
  • 184. SMO Clinical Research
  • 185. SMO ClinPlus
  • 186. Society for Clinical Research Sites
  • 187. Spectrum Clinical Research
  • 188. Spinal Cord Injury Network
  • 189. Splash Clinical
  • 190. SubjectWell
  • 191. SWOG Cancer Research
  • 192. Syneos Health
  • 193. Synexus
  • 194. TFS
  • 195. The Academic Network
  • 196. The Patient Experience Project
  • 197. The Patient Recruiting Agency
  • 198. The Patient Recruitment Consultancy
  • 199. ThreeWire
  • 200. Topstone Research
  • 201. Total Clinical Trial Management
  • 202. Trial Connections
  • 203. Trialfacts
  • 204. TrialJoin
  • 205. TrialSpark
  • 206. TrialWire
  • 207. Tudor Reilly Health
  • 208. Roche
  • 209. United BioSource
  • 210. University of Exeter
  • 211. University of Glasgow
  • 212. University of Strathclyde
  • 213. Veristat
  • 214. Viomedo
  • 215. VisibilityRx
  • 216. Vizae Clinical Trial Management
  • 217. WCCT Global
  • 218. WIRB-Copernicus Group
  • 219. Worldwide Clinical Trials
  • 220. X Factor Advertising
Back to Top